Ketamine and problems with advanced palliative care in the community setting

Baumrucker SJ : Clinical research on heroin in cancer pain control. American Journal of Hospice & Palliative Care. January/February 2000; 17(1): 8-9.

Hewitt, DJ : The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain. 2000; 16 (2 Suppl): S73-S79.

Wiesenfeld-Hallin Z : Combined opioid-NMDA antagonist therapies: What advantages do they offer for the control of pain syndromes? Drugs. January 1998; 55(1): 1-4.

Belozertseva IV , et al. : Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice. Naunyn Schmiedebergs Arch Pharmacol. 2000; 361(6): 573-577.

Bonezzi C , Demartini L : Treatment options in postherpetic neuralgia. Acta Neurol Scan Suppl. 1999; 173: 25-35.

Klepstad P , Borchgrevink PC : Four years treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia. Acta Anaesthesiol Scand. 1997; 41(3): 422-426.

Berman RM , et al. : Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000; 47(4): 351-354.

Rabben T , et al. : Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 1999; 289(2): 1060-1066.

Bell RF : Low dose subcutaneous ketamine infusion and morphine tolerance. Pain. 1999; 83(1): 101-103.